GlassScriptPhysician profile
Melissa Becker
NPI 1093730350
$1,474.91
in general payments reported to CMS, 2019-2025
12 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.30 · 2023: $58.09 · 2024: $50.16 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753 · Travel and Lodging: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.17 |
| Travel and Lodging | $654.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $654.44 | 2025 | Proclaim |
| Foundation Fusion Solutions, LLC | $201.08 | 2025 | |
| Boston Scientific Corporation | $190.86 | 2024-2025 | Intracept, Watchman Flx |
| Saluda Medical Americas, INC. | $112.26 | 2025 | Evoke |
| Globus Medical, INC. | $76.37 | 2025 | Senza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.09 | 2023 | Lifevest |
| Tela Bio, INC. | $52.52 | 2021 | |
| Abbvie INC. | $50.02 | 2025 | |
| Nalu Medical, INC. | $26.22 | 2025 | Nalu Neurostimulation System |
| Endo Pharmaceuticals INC. | $23.18 | 2024 | Xiaflex |
| Fidia Pharma USA INC. | $15.09 | 2025 | Triluron, Hymovis |
| Smith+Nephew, INC. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.